SCHEMBL186257

SCHEMBL186257

Cn1ncc(OC(=O)O)cc1=O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.42
HTR3A P46098 3/20 0.35
GRM5 P41594 1/20 0.33
KMT2A Q03164 5/20 0.33
CYP1A2 P05177 4/20 0.33
CYP2C9 P11712 3/20 0.33
MAPT P10636 4/20 0.31
NFE2L2 Q16236 1/20 0.31
ALDH1A1 P00352 3/20 0.31
HPGD P15428 3/20 0.31
CREBBP Q92793 1/20 0.31
MCHR1 Q99705 1/20 0.30
F2 P00734 1/20 0.30
GLA P06280 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL979263 0.77 HTR3A (0.38) PTGS1HTR3AKMT2AMAPTALDH1A1
SCHEMBL248731 0.72 L3MBTL1 (0.39) KMT2AALDH1A1MEN1
SCHEMBL186256 0.72 PTGS1 (0.49) PTGS1KMT2ACYP2C9ALDH1A1HPGD
SCHEMBL26122020 0.70 HAO1 (0.46) CYP2C9MAPTALDH1A1HPGDCYP2C19
SCHEMBL9707251 0.70 HAO1 (0.46)
SCHEMBL17582560 0.69 PTGS1 (0.46) PTGS1HTR3AKMT2ACYP1A2MAPT
SCHEMBL14856800 0.69 HAO1 (0.38) KMT2ACYP1A2CYP2C9MAPTHPGD
SCHEMBL4078995 0.68 ATM (0.47) PTGS1MAPTALDH1A1HPGDLMNA
SCHEMBL686904 0.68 KMT2A (0.40) KMT2AMAPTMEN1
SCHEMBL15768034 0.67 KMT2A (0.40) KMT2ACYP1A2MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed